BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33022391)

  • 1. Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy.
    Merckx P; Lammens J; Nuytten G; Bogaert B; Guagliardo R; Maes T; Vervaet C; De Beer T; De Smedt SC; Raemdonck K
    Eur J Pharm Biopharm; 2020 Dec; 157():191-199. PubMed ID: 33022391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
    Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
    Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating β
    Merckx P; Conickx G; Blomme E; Maes T; Bracke KR; Brusselle G; De Smedt SC; Raemdonck K
    Eur J Pharm Biopharm; 2024 Apr; 197():114223. PubMed ID: 38367760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
    De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
    J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophages.
    De Backer L; Naessens T; De Koker S; Zagato E; Demeester J; Grooten J; De Smedt SC; Raemdonck K
    J Control Release; 2015 Nov; 217():53-63. PubMed ID: 26307350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery system.
    De Backer L; Braeckmans K; Stuart MC; Demeester J; De Smedt SC; Raemdonck K
    J Control Release; 2015 May; 206():177-86. PubMed ID: 25791835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
    Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
    Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
    Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
    Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
    Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
    Murgia X; Gastiasoro E; Mielgo V; Alvarez-Diaz F; Lafuente H; Valls-i-Soler A; Gomez-Solaetxe MA; Larrabe JL; Rey-Santano C
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):81-7. PubMed ID: 21410324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulizing poractant alfa versus conventional instillation: Ultrastructural appearance and preservation of surface activity.
    Minocchieri S; Knoch S; Schoel WM; Ochs M; Nelle M
    Pediatr Pulmonol; 2014 Apr; 49(4):348-56. PubMed ID: 24039226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Nebulization on the Physicochemical Properties of Polymer-Lipid Hybrid Nanoparticles for Pulmonary Drug Delivery.
    Gonsalves A; Menon JU
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like Mechanism of Action.
    Guagliardo R; Herman L; Penders J; Zamborlin A; De Keersmaecker H; Van de Vyver T; Verstraeten S; Merckx P; Mingeot-Leclercq MP; Echaide M; Pérez-Gil J; Stevens MM; De Smedt SC; Raemdonck K
    ACS Nano; 2021 May; 15(5):8095-8109. PubMed ID: 33724778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel delivery system for supraglottic atomization allows increased lung deposition rates of pulmonary surfactant in newborn piglets.
    Nord A; Linner R; Milesi I; Zannin E; di Castri M; Bianco F; Dellacá RL; Cunha-Goncalves D; Perez-de-Sa V
    Pediatr Res; 2020 May; 87(6):1019-1024. PubMed ID: 31785590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.
    De Backer L; Braeckmans K; Demeester J; De Smedt SC; Raemdonck K
    Nanomedicine (Lond); 2013 Oct; 8(10):1625-38. PubMed ID: 23418856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNA.
    Guagliardo R; Merckx P; Zamborlin A; De Backer L; Echaide M; Pérez-Gil J; De Smedt SC; Raemdonck K
    Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31450805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
    Mimi H; Ho KM; Siu YS; Wu A; Li P
    J Control Release; 2012 Feb; 158(1):123-30. PubMed ID: 22094103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalation Properties and Stability of Nebulized Naked siRNA Solution for Pulmonary Therapy.
    Tahara K; Hashimoto W; Takeuchi H
    Chem Pharm Bull (Tokyo); 2016; 64(1):63-7. PubMed ID: 26726746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
    Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
    J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.